"Liver" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
| Descriptor ID |
D008099
|
| MeSH Number(s) |
A03.620
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Liver".
Below are MeSH descriptors whose meaning is more specific than "Liver".
This graph shows the total number of publications written about "Liver" by people in this website by year, and whether "Liver" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 9 | 7 | 16 |
| 1995 | 9 | 12 | 21 |
| 1996 | 5 | 15 | 20 |
| 1997 | 10 | 8 | 18 |
| 1998 | 6 | 11 | 17 |
| 1999 | 8 | 13 | 21 |
| 2000 | 3 | 14 | 17 |
| 2001 | 13 | 13 | 26 |
| 2002 | 10 | 15 | 25 |
| 2003 | 8 | 15 | 23 |
| 2004 | 9 | 19 | 28 |
| 2005 | 14 | 20 | 34 |
| 2006 | 19 | 17 | 36 |
| 2007 | 8 | 14 | 22 |
| 2008 | 13 | 20 | 33 |
| 2009 | 10 | 13 | 23 |
| 2010 | 11 | 18 | 29 |
| 2011 | 10 | 14 | 24 |
| 2012 | 5 | 10 | 15 |
| 2013 | 12 | 11 | 23 |
| 2014 | 13 | 10 | 23 |
| 2015 | 18 | 16 | 34 |
| 2016 | 19 | 10 | 29 |
| 2017 | 17 | 14 | 31 |
| 2018 | 9 | 13 | 22 |
| 2019 | 11 | 9 | 20 |
| 2020 | 8 | 9 | 17 |
| 2021 | 10 | 14 | 24 |
| 2022 | 2 | 22 | 24 |
| 2023 | 2 | 21 | 23 |
| 2024 | 2 | 8 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver" by people in Profiles.
-
LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS. Radiology. 2024 Dec; 313(3):e240169.
-
Semaglutide 2.4?mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial. Aliment Pharmacol Ther. 2024 Dec; 60(11-12):1525-1533.
-
Body composition and muscle composition phenotypes in patients on waitlist and shortly after liver transplant - results from a pilot study. BMC Gastroenterol. 2024 Oct 09; 24(1):356.
-
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA. 2024 09 24; 332(12):1013-1014.
-
The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors. Radiology. 2024 09; 312(3):e233051.
-
Congestive Hepatopathy: Pathophysiology, Workup, and Imaging Findings with Pathologic Correlation. Radiographics. 2024 05; 44(5):e230121.
-
Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis. Nutr Clin Pract. 2024 Jun; 39(3):634-640.
-
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 02 08; 390(6):497-509.
-
Hepatic glucagon action: beyond glucose mobilization. Physiol Rev. 2024 Jul 01; 104(3):1021-1060.
-
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFß signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Ther. 2024 Apr; 31(4):574-585.